Technology

Neurology CT

Cardiac CT

Women's Health CT

Oncology CT

Facility Management

Neurology MRI

Oncology MRI

Women's Health MRI

Cardiac MRI

Mammography

Molecular Imaging

Women's Health Ultrasound

Oncology Ultrasound

Cardiac Ultrasound

Ultrasound

Orthopedic X-Ray

X-Ray

News

All News

Blogs

Media

Around the Practice 

Between the Lines

Image IQ

Medical World News

Podcasts

Rad-View

Videos

Conferences

Conference Coverage

Conference Listing

DI Executive

Resources

CME/CE

E-books

Education

Interactive Tool Kits

Partners

Subscribe

Advertise

About

Contact Us

Editorial

Editorial Board

Do Not Sell My Personal Information 

Privacy

Terms and Conditions

Diagnostic Imaging

Facebook

LinkedIn

YouTube

Spotlight

Disease Spotlight: Prostate Cancer

Image IQ Quiz

RSNA

Rad View: PSMA PET Imaging Recommendations

Rad-View: Generic Contrast Agents 

Unlock AI-Powered Imaging

Topics

View More

1rem

View

PSMA PET in Clinical Practice: Optimizing Prostate Cancer Management 

Clinical

Video Series

The Role of PSMA PET in Early Detection and Prostate Cancer Staging 

Jaideep Sohi, MD, and Jeremie Calais, MD, examine advanced prostate cancer imaging techniques, focusing on PSMA PET and gallium-based modalities, their role in detecting oligometastatic disease, integration with multidisciplinary care teams, and strategies for optimizing clinical outcomes across the spectrum of prostate cancer management.

Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.

PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

Key opinion leaders analyze the advantages of integrating PSMA PET imaging with traditional imaging techniques to enhance prostate cancer management and treatment strategies.

Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care 

Experts in radiology imaging evaluate the impact and efficacy of PSMA PET in improving early detection methods and refining prostate cancer staging processes.

Key opinion leaders examine the role of advanced imaging agents, particularly PSMA PET and other radiotracers, in identifying and defining oligometastatic disease in patients with prostate cancer.

Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging 

Jaideep Sohi, MD, and Jeremie Calais, MD, explore the complexities of managing oligometastatic disease, emphasizing the critical role of accurately assessing lesion counts, metastatic spread, and disease thresholds in optimizing clinical outcomes.

Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice 

Medical experts conduct a comparative assessment of gallium-based and non-gallium-based imaging agents to determine their efficacy in detecting and characterizing oligometastatic prostate cancer.

Evaluating Imaging Agents in Oligometastatic Prostate Cancer: A Comparative Analysis of Gallium-Based and Non-Gallium-Based Options 

Jaideep Sohi, MD, and Jeremie Calais, MD, conduct a comparative assessment of gallium-based and non-gallium-based imaging agents for their efficacy in detecting and characterizing oligometastatic prostate cancer.

Optimal Timing and Frequency of Imagining Agents Used in the Detection and Characterization of Oligometastatic Prostate Cancer

Key opinion leaders explore the significance of interdisciplinary collaboration in prostate cancer management, with a focus on how PSMA PET imaging enhances decision-making processes within multidisciplinary care teams.

Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams 

Medical experts address challenges and propose solutions for inter-readability concerns in nuclear medicine, particularly focusing on strategies to overcome the scarcity of specialized readers.

Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability 

Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.

Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging 

The Role of PSMA PET in Early Detection and Prostate Cancer Staging

EP: 1.PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

EP: 2.Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care

EP: 3.The Role of PSMA PET in Early Detection and Prostate Cancer Staging

EP: 4.Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

EP: 5.Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice

EP: 6.Evaluating Imaging Agents in Oligometastatic Prostate Cancer: A Comparative Analysis of Gallium-Based and Non-Gallium-Based Options

EP: 7.Optimal Timing and Frequency of Imagining Agents Used in the Detection and Characterization of Oligometastatic Prostate Cancer

EP: 8.Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams

EP: 9.Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability

EP: 10.Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging